- Home
- PXLW vs FGEN Comparison
PXLW vs FGEN Comparison
Compare PXLW & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- FGEN
- Stock Information
- Founded
- PXLW 1997
- FGEN 1993
- Country
- PXLW United States
- FGEN United States
- Employees
- PXLW N/A
- FGEN N/A
- Industry
- PXLW Semiconductors
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- PXLW Technology
- FGEN Health Care
- Exchange
- PXLW Nasdaq
- FGEN Nasdaq
- Market Cap
- PXLW 28.1M
- FGEN 33.5M
- IPO Year
- PXLW 2000
- FGEN 2014
- Fundamental
- Price
- PXLW $7.99
- FGEN $7.69
- Analyst Decision
- PXLW Strong Buy
- FGEN Strong Buy
- Analyst Count
- PXLW 2
- FGEN 1
- Target Price
- PXLW $15.00
- FGEN $250.00
- AVG Volume (30 Days)
- PXLW 73.1K
- FGEN 74.7K
- Earning Date
- PXLW 08-06-2025
- FGEN 08-05-2025
- Dividend Yield
- PXLW N/A
- FGEN N/A
- EPS Growth
- PXLW N/A
- FGEN N/A
- EPS
- PXLW N/A
- FGEN N/A
- Revenue
- PXLW $34,246,000.00
- FGEN $6,996,000.00
- Revenue This Year
- PXLW $5.21
- FGEN N/A
- Revenue Next Year
- PXLW $35.68
- FGEN N/A
- P/E Ratio
- PXLW N/A
- FGEN N/A
- Revenue Growth
- PXLW N/A
- FGEN N/A
- 52 Week Low
- PXLW $4.67
- FGEN $4.50
- 52 Week High
- PXLW $14.16
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- PXLW 60.10
- FGEN 63.73
- Support Level
- PXLW $6.71
- FGEN $5.37
- Resistance Level
- PXLW $7.67
- FGEN $5.73
- Average True Range (ATR)
- PXLW 0.52
- FGEN 0.51
- MACD
- PXLW 0.02
- FGEN 0.32
- Stochastic Oscillator
- PXLW 66.67
- FGEN 97.26
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.